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Preterm birth research is poised to explore the mental health of adults born very preterm(VP;<32+0 
weeks gestational age) and/or very low birth weight(VLBW; <1500g) through individual 
participant data meta-analyses, but first the previous evidence needs to be understood. We 
systematically reviewed and assessed the quality of the evidence from VP/VLBW studies with  
mental health symptoms or disorders appearing in adulthood, excluding childhood onset disorders. 
Participants (≥18 years, born >1970) included VP/VLBW individuals with controls born at 
term(≥37+0 weeks) or with normal birth weight(NBW; ≥2500g). Thirteen studies were included. 
Studies consistently showed an increased risk for psychotropic medication use for VP/VLBW 
adults in comparison to NBW/term controls, but whether VP/VLBW adults have an increased risk 
for mental health disorders or symptoms appearing in adulthood remains uncertain. The quality of 
the evidence was moderate (65.8%) to high (34.2%). Further research in larger samples is needed. 
Keywords: European Union, EU, Horizon 2020, RECAP, PremLife, Preterm, Premature, very 
low birth weight, VLBW, very preterm, VP, review, mental disorder, psychiatric disorder, 




Globally, 10.6% of all births are preterm (<37 weeks of gestation), equating to 14.8 million live 
preterm births annually—a statistic which has increased since 2000[1]. In light of the continued 
global prevalence, and in conjunction with a now critical mass of preterm born adults who survived 
following the modern neonatal medicine era (post 1970)[2–4], research has begun to unravel the 
long-term consequences of preterm birth. Facilitated by the maturation of preterm birth study 
cohorts, the literature now provides significant evidence of developmental adversities across the 
lifespan[5–9]. However, findings are mixed on whether or not individuals born preterm have 
increased risk of developmental problems or disorders. In part, mixed results may be due to the 
limited number of individuals born preterm at different gestational ages in existing cohort studies, 
preventing more gestational age specific analyses, as well as the ability to control for other macro 
and micro level factors, which may contribute to risk or resiliency in certain groups.  
 
Those Very Preterm (VP; <32+0 weeks’ gestation), constitute 15.3% of preterm births globally 
each year [1]. VP born individuals have been reported to have mean birth weight of 1810 (males) 
and 1750 (females) grams (g) at 31 completed weeks’ gestation, decreasing approximately to 1500 
g by week 30[10]. Hence, very low birth weight (VLBW; <1500g) is often synonymously used for 
exploring outcomes of VP born individuals. VP and VLBW born individuals have increased risks 
for physical and mental health adversities across the lifespan [5] corresponding to a significant 
economic burden in health and social care costs [11]. Mental health adversities, highlighted by 
high quality Nordic register studies, show VP born adults have increased risks for psychiatric 
hospitalization, nonaffective psychosis, depressive disorder, bipolar affective disorder, autism 
spectrum disorders, attention-deficit/hyperactivity disorders, major/minor psychiatric diagnoses 
and eating disorders [12–16] across the lifespan. However, these findings do not differentiate the 
outcomes of adults from adolescents.  
 
Three international projects RECAP Preterm[17], PremLife[18], and APIC (Adults Born Preterm 
International Collaboration)[19] are currently consolidating datasets from preterm birth cohort 
studies to afford gestational age specific meta-analyses of long term outcomes, which will allow 
for further adult preterm risk and resiliency research and for aggregate-data and individual 
participant data (IPD) meta-analyses. Accordingly, understanding the pre-existing evidence on 
mental health outcomes in VP/VLBW born adults, as well as discerning the quality of such 
evidence is a crucial and timely step for research. To our knowledge, no systematic reviews have 
focused on mental health outcomes of VP/VLBW born individuals that can have their onset in  
adulthood (≥18 years), namely on mood, anxiety, substance use, personality and schizophrenia 
spectrum disorders, nor has the overall quality of the existing evidence been assessed. Hence, this 
systematic review sought to crystalize the evidence on VP/VLBW born mental health outcomes 
appearing in adulthood and to explore the limitations and strengths of previous research as a way 
forward for the future. Disorders that by diagnostic definition have childhood onset, including 
psychological development disorders (e.g. autism spectrum disorders), behavioral and emotional 
disorders of childhood onset (e.g. attention-deficit/hyperactivity disorder), and intellectual 




Inclusion criteria (B) 
 
Any longitudinal case-control studies, cohort studies, registry studies, meta-analyses and 
Randomized Controlled Trials with gestational age or birth weight as the exposure and mental 





Study participants included VP or VLBW participants, as well as participants classified as 
Extremely Preterm (EP; <28+0 weeks of gestation) or Extremely Low Birth Weight (ELBW; <1000 
g). The controls included participants born at term (≥37+0 weeks of gestation) or participants born 




Exposure variables included VP birth status or VLBW defined in accordance with the WHO [20] 




We considered all covariates and confounders for eligibility and no exclusions were made based 
on these. However, we used predefined covariates for the quality of evidence assessment. Familial 
genetic confounding adjusted for via twin or sibling study design was the key covariate. 
Additionally, maternal age or parity, family/childhood socioeconomic status (SES; indexed by 
parental education, occupation or income), parental mental health, neonatal complications 
(perinatal asphyxia and birth traumas, neonatal hypoglycemia, neonatal respiratory disorders, low 
apgar scores, factors leading to NICU admission, brain injury), participant age/birth year and 




Outcomes included diagnoses of mental health disorders or symptoms in adulthood. These 
included any outcome for mood disorders, depression, bipolar disorder, anxiety, internalizing 
symptoms or externalizing symptoms.  
Since the review sought to elucidate mental health disorders appearing in adulthood, disorders 
defined with onset in childhood by the International Classification of Diseases, Tenth Revision 
(ICD-10)[21] i.e. Attention-Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum 




Only birth cohort and register studies including individuals born after 1970 were included, to 
account for the major changes in neonatal care.  
 
Setting(B) 




Study exclusion criteria included self-reported gestational age or birth weight of VP/VLBW 
groups, and study designs i.e. qualitative studies, poster sessions, conference abstracts, letters to 
the editor, reviews and retrospective studies. Additionally, any cohorts born before 1970 and 
studies with participants below the age of 18 years were excluded. Duplicate studies reporting the 
same outcome measure for the same cohort or population at the same follow-up time point were 
also excluded. In which case, the report with the largest sample size at that particular time point 
was considered the most relevant. In the case of the same results being reported by an individual 
cohort study and in an aggregate data or IPD meta-analysis, the meta-analysis was included if all 
of the studies in the meta-analysis met the inclusion criteria and the individual studies were 
excluded.  
 
Search & Study Selection(B) 
 
Systematic search strategies were applied in PubMed, Web of Science and PROQUEST from 
inception to October 2019. Studies identified from grey literature were also included. The search 
strategies are provided in Supplementary material A.1. All duplicate studies were removed. Study 
inclusion and exclusion were determined by the predefined criteria set out above. Study selection 
occurred in two rounds. First, title and abstract review for relevance; second, full-text review to 
determine final inclusion.  
See PRISMA flow diagram for more details (Figure 1).  
 




The reviewers extracted pre-specified study characteristics, i.e. cohort name, sample size, exposure 
and outcome definitions, covariates, year of birth, location, age at assessment and study results 
from each study, using a uniform template.  
 
Quality of Evidence Assessment(B) 
 
Two reviewers (RR and MLP) independently assessed quality of evidence for all included studies 
using the Newcastle-Ottawa Scale (NOS) using pre-specified ‘acceptable’ criteria for each 
domain. The NOS assesses studies based on three domains: Selection, Comparability, and 
Outcome. Studies could receive up to nine stars, four stars in the ‘Selection’ for 1) 
Representativeness of the exposed cohort, 2) Selection of the non-exposed cohort, 3) 
Ascertainment of the exposure, and 4) Demonstration that the outcome of interest was not present 
at the start of the study exposure. Studies could receive another two stars for ‘Comparability’ for 
5) Comparability of cohorts based on the design or analysis, and 6) Study controls for at least 3 
additional risk factors. The final three stars for the ‘Outcome’ domain were awarded on the bases 
of 7) Assessment of outcome, 8) Was follow-up long enough for outcomes to occur, and 9) 
Adequacy of follow up of cohorts. The acceptable criteria used by both assessors for each item is 
reported in Supplementary Table B.2. If the assessors disagreed, then a consensus was reached 
with a third assessor (KH). Studies with ≥7 were rated as ‘High’ quality, studies with 4-6 received 
a ‘Moderate’ quality rating, and studies with <4 stars received a ‘poor’ quality rating. See 




Summary of Included Studies (B) 
 
Thirteen studies met the inclusion criteria, with data from eight cohorts and two national register 
studies. The included studies comprise cohorts from Australia (Royal Women’s Hospital), Canada 
(McMaster), Finland (Helsinki Study of Very Low Birth Weight Adults, HeSVA), Germany 
(Bavarian Longitudinal Study, BLS), New Zealand (NZ VLBW), Norway (Trondheim), UK and 
the Republic of Ireland (EPICure), and USA (Cleveland) and populations from Sweden (Swedish 
MBR) and Norway (Norwegian MBR). The birth years range from 1977-1995 with follow-up ages 
ranging from 18-35 years in the included studies. Studies reported outcomes for any mental 
disorder, and total problems and related symptoms (n=10), mood, depression, bipolar and anxiety 
disorders, and internalizing problems and related symptoms (n=12), substance use disorders, and 
externalizing problems and related symptoms (n=7), eating disorders and symptoms (n=3), 
schizophrenia spectrum disorders and symptoms (n=3), and psychiatric medication use (n=3). Four 
studies reported exposures as EP or VP, while 10 studies reported exposures as ELBW or VLBW. 
Two studies indicated the control exposure as NBW, while 11 studies used term birth as the control 
exposure, and two studies defined the controls as NBW term born individuals. See Table 1 for 
included studies by outcome and publication year. Table 1 also shows the method of the outcome 
measurement. 
INSERT TABLE OF INCLUDED STUDIES HERE 
 
Any mental disorder and total problems and related symptoms (B) 
 
Two studies with participants aged 26-35 years reported an increased risk of any mental disorder, 
measured by structured clinical interviews, in VLBW/ELBW adults compared to term-born/NBW 
controls[22,23]. In contrast, one study showed no significant difference in the risk of any mental 
disorder, also identified from a structured clinical interview, between 24-29-year-old VLBW and 
NBW participants [24]. 
 
Seven cohorts with participants aged 19-29 years reported total problem scores with self-reported 
symptoms scales. Six of these studies were included in an IPD meta-analysis [25], which found no 
differences in self-reported total problem scores between 18-28-year-old VP/VLBW and term 
participants. However, one study [26] which was included in the IPD meta-analysis at a younger 
age (20 years), reported that VLBW participants had significantly higher total problem scores than 
term born appropriate for gestational age (AGA) controls in a follow-up at an older age (26 
years)[26]. Furthermore, the EPICure cohort, which was not included in the meta-analysis, also 
reported a significantly higher total difficulties score in 19-year-old EP  individuals compared with 
term controls[27]. 
 
Mood, depression, bipolar and anxiety disorders and internalizing problems and related symptoms 
(B) 
 
Two studies showed that the risk of mood disorders [22,28] and one showed that the risk of 
depression[24] in a structured clinical interview were higher in 26-29-year-old VLBW/VP 
participants compared to term/NBW controls. However, one of these studies reported that the 
group difference in mood disorders was not significant when accounting for multiple testing[28]. 
 
In contrast, three studies in 22-35-year-old participants [23,29,30] found no differences in the risk 
of major depressive disorder or self-reported depression diagnosis between VLBW/ELBW and 
term controls, and one study which focused on bipolar disorder did not test the differences because 
of small number of cases. However, in one of these studies [29] self-reported depression diagnosis 
was more frequent among VLBW small for gestational age (SGA) participants and less frequent 
among VLBW appropriate for gestational age (AGA) participants than among term born controls.  
 
One study [22] reported an increased risk of anxiety disorders in a structured clinical interview at 
age 26 years. Whereas, five other studies which measured anxiety disorders also via  structured 
clinical interview reported no differences for VLBW/ELBW/VP compared to term controls in any 
anxiety disorder [24,28,30], Generalized Anxiety Disorder (GAD), panic disorder, social phobia 
or obsessive-compulsive disorders [22,23]. However, one of these studies was not able to pursue 
testing differences in agoraphobia, social phobia, specific phobia, panic, obsessive compulsive and 
post-traumatic stress disorders between VLBW and term born controls because of lack or small 
number of cases[22]. 
 
The APIC IPD meta-analysis[25]found an increased risk of self-reported internalizing symptoms 
for VP/VLBW participants, and for subscales, including avoidant personality problems[25], but 
found no differences in its withdrawn, somatic complaints and anxious/depressive subscales. One 
study included in the IPD meta-analysis at 20 years, also reported increased internalizing 
symptoms and the withdrawn behavior and somatic complaints subscale scores later at 26 years, 
but did not report differences in a subscale measuring depressive/anxiety symptoms [26]. One 
other study also reported significantly increased emotional symptoms in EP  participants compared 
to term controls at age 19 [27].  
 
With regard to depressive symptoms, one study reported that VLBW adults scored higher than 
NBW controls at age 24-29 years [24].  However, one study reported that the depressive symptoms 
scores were higher for those born VLBW and SGA and lower for those born VLBW and AGA 
than for term controls at the age of 18-27 years [29]. Yet, another study [31] found no differences 
in depressive symptoms scores between VLBW participants and term born controls. One study 
reported no differences for anxiety, phobic anxiety and obsessive compulsive disorder symptoms 
in VLBW participants compared to NBW controls[24].  
 
Substance use disorders, and externalizing problems and related symptoms(B) 
 
Three studies[22–24] reported no differences in risk of substance use disorder between 
VLBW/ELBW participants compared to NBW/term controls at age 24-36 years. One of the 
studies[22] also reported separately no differences for alcohol or drug dependencies.  
 
One IPD meta-analysis[25] found a decreased risk for externalizing symptoms and for scales 
measuring rule-breaking, intrusive and antisocial personality problems in VLBW/EP  participants 
compared with term born controls. In contrast, the Trondheim study included in the meta-analysis 
at age 20, reported significantly increased externalizing problems in the VLBW participants 
compared to term born controls in a later follow-up at age 26, but found no difference in subscales 
measuring aggressive or rule-breaking behavior [26]).  One study found no differences in conduct 
problems between ELBW and term-born participants at age 19 [27]. 
 
Eating disorders and related symptoms(B) 
 
Three studies assessed eating disorders, or symptoms thereof, in VLBW born adults [22,24,32]. 
One study[22] found no cases with eating disorders in either the VLBW or term groups, another 
study[24] found no differences between VLBW participants and NBW controls in eating disorders, 
while another study [32] found a decreased risk of eating disorder symptoms in VLBW adults 
compared to term born controls at age 18-27 years.  
 
Schizophrenia spectrum disorders and related symptoms(B) 
 
Only three studies, two from the same cohort, assessed schizophrenia spectrum disorders or their 
symptoms [22,24,26]. One study reported no differences between VLBW and NBW controls in 
psychotic and bipolar disorders, measured with a clinical interview, as one clinical entity, or in 
psychoticism or paranoid ideation symptoms at age 24-29 years [24]. In the other study, 
differences in psychotic disorders could not be examined because of small number of cases[22], 
but individuals born VLBW had significantly more frequent delusion inventory scores above the 
clinical cutoff than term-born peers at age 26 years[26], although there were no difference in 
continuous delusion scores.  
 
Psychotropic medication use(B) 
 
Two large scale population-based studies [33,34] on psychotropic medication use with prescription 
register data from the Nordic countries reported an increased risk of being prescribed any 
psychotropic medications in both VP and EP  participants compared to term born controls at age 
24-35 years.  
 
One additional study has reported that self-reported antidepressant medication use is higher among 
VLBW participants born SGA than among term born controls, with no difference between all 
VLBW adults compared to controls at age 18-27 years[29]. 
 
Table of Excluded Studies(B) 
 
All studies excluded after full-text review are listed in the Table of Excluded Studies, along with 
a brief indication of the reason for exclusion. See Supplementary Table B.1 Excluded Studies.  
 
Quality of Evidence Assessment(B) 
 
As several studies reported multiple outcomes of varying quality, studies were rated individually 
by outcome. Hence, some studies have multiple quality ratings depending on the number of 
outcomes. Due to the systematic review study inclusion criteria, 0 studies were judged to have 
poor quality, 25 study outcomes were rated to have moderate quality(65.8%), and 13 were rated 
as high(34.2%). Notably, none of the included studies accounted for all of the important, pre-
specified covariates, namely genetic confounding, which could have been addressed for instance 
using a sibling or twin study design. Although, several studies did adjust for some of the predefined 
key covariates such as sex(n=10), age/birth year(n=9), and SES/parental education (n=13), while 
parental mental health(n=2), neonatal complications i.e. brain injury (n=1), or parity(n=1) were 
accounted for in far less studies. Hence, the comparability of the study findings downgraded the 
results in all studies. In spite of this, overall, we judged the quality of evidence for all outcome 
domains to be moderate to high quality. See Table 1 Summary of Main Findings for Included 





Summary of Evidence(B) 
 
Our review found that the odds of any psychotropic medication use, derived from nationwide 
registers in two population-based studies, was 1.3[33] to 2.1-times [34]higher for VP adults, and 
in one cohort study self-reported antidepressant medication use was 4.0-times higher for VLBW 
adults born SGA than for term controls [29]. However, our review suggests, that the evidence on 
whether VP/VLBW adults have higher risk of mental health disorders appearing in adulthood than 
term/NBW controls and whether they differ in the symptoms of these disorders, remain uncertain 
[22–34].  Although, the findings lack consensus, it may not be for the lack of quality in the 
evidence in the studies we reviewed, as the studies were overall moderate to high quality, with 
none rated as poor quality. However, it does suggests the need for larger study samples.  
 
Of the three studies that tested the risk of any mental health disorder, a significantly higher risk for 
VP/VLBW adults in comparison to NBW/term controls was reported in two, while in one this risk 
was not significant. Of the six studies that tested the risk of mood disorders, three reported a 
significantly higher risk for any mood/depressive disorder, while three reported that the risk for 
depressive/major depressive disorder was not significant. Of the five studies that tested the risk of 
anxiety disorders, one reported a significantly higher risk for any anxiety disorder, three reported 
that this risk was not significant, and one reported that the risk for GAD, social phobia, panic or 
obsessive-compulsive disorders was not significant. Three studies focused on substance use 
disorders and found no significant elevation in the risk, and the two studies that focused on eating 
and schizophrenia spectrum disorders reported no significant elevation in the risk.  Moreover, in 
one of the studies, which suggested that the risk for any mood disorder was higher, the differences 
between VP/VLBW and term/NBW controls were no longer significant when accounting for 
multiple testing. As well as in four studies, which focused on depressive, bipolar, panic disorders, 
agoraphobia, social phobia, specific phobia, GAD, OCD, PTSD, eating, schizophrenia spectrum 
disorders, VP/VLBW and term/NBW comparisons could not be performed because the number of 
cases in the VP/VLBW and/or in NBW/term control groups were small or zero.  
 
Of the studies that tested differences between VP/VLBW adults and term controls in symptoms of 
mental disorders, significant differences in total, internalizing and/or externalizing problems were 
reported in nine, while no differences were reported in three. Among these studies is an IPD meta-
analysis of six cohort studies. It reported no differences between VP/VLBW adults and NBW/term 
controls in total problems, and higher levels of internalizing and lower levels of externalizing 
problems for VP/VLBW adults than for NBW/term controls. Furthermore, one study reported that 
VP/VLBW adult showed higher levels of clinically relevant schizophrenia spectrum disorder 
symptoms than NBW/term controls, one reported no such differences, and one additional study 
reported that VP/VLBW adults displayed lower levels of eating disorder symptoms than 
NBW/term controls.  
 
While this mixed pattern of findings in relation to mental health disorders appearing in adulthood 
and their symptoms is in contrast with the two population-based studies showing increased risk of 
any psychotropic medication use for VP/VLBW adults, the major reason for this discrepancy 
appears to relate to differences in sample sizes. While the two population-based samples included 
980 and 3670 VP adults and 243283 and 588410 term controls, respectively, in all but two 
individual cohort studies focusing on mental health disorders and symptoms were the VP/VLBW 
and/or NBW/term control group sizes less than 100. The IPD meta-analysis included 747 
VP/VLBW and 1512 term controls. Hence, these findings suggest that before any firm conclusions 
about longer-term mental health outcomes of VP/VLBW adults can be made, much larger 
individual cohort studies than those conducted thus far and aggregate-data and IPD meta-analyses 
are urgently needed. In favor of this view are the five large, population-wide studies of over 4.6 
million VP/VLBW adults and NBW/term controls, which have demonstrated an increased risk of 
a host of mental health disorders for VP/VLBW born adults [12,13,16,35,36], which however did 




Limitations & Strengths(B) 
 
The limitations of this systematic review stem largely from the limitations in the current body of 
evidence. A key limitation in all included studies comes from a lack of control for familial genetic 
confounding, accountable for through sibling and twin study designs. Furthermore, the small 
sample sizes in most studies limits the generalizability of the findings, the limited statistical power 
increasing the likelihood of both false positive and false negative findings, as well as limiting the 
exploration of outcomes with lower prevalence rates and exploration of important covariates, 
confounders, and moderators. The lack of uniform adjustment for important covariates across 
studies, such as a genetic confounding, childhood SES, parental mental health, neonatal 
complications, parity, participant age, and sex, further reduces the comparability of the findings. 
Furthermore, three cohorts retrospectively recruited controls[23,25,27]and did not clearly report if 
their gestational age or birthweight was verified. Hence, these cohorts may have used retrospective 
self-reports which are prone to bias.  It is also important to note that although we excluded 
duplicate publications of the same outcome at the same age from the same cohort, most of the 
included cohorts provided multiple outcomes, either at a different time point or with a different 
measure. Therefore, a large portion of the findings reported in this review come from a select group 
of cohorts. Many of the studies also have used self-reports of mental health, not gold standard 
diagnostic interviews, precluding inferences to diagnosed disorders. 
 
Our review focused on mental health outcomes appearing in adulthood. While we excluded the 
mental disorders, which have childhood onset by definition, some of the included disorders with 
possible adulthood onset (e.g. anxiety disorders) also may have had their onset in childhood or 
adolescence[37]. Mental disorders and psychiatric symptoms show both homotypic and 
heterotypic continuity from childhood to adulthood, with childhood internalizing and externalizing 
problems predicting both internalizing and externalizing disorders and their symptoms in 
adulthood [27,37–40]. Such continuity is present also in EP children: the EPICure study, showed 
clinically significant total psychiatric problems at age 2.5 years predicted increased total 
psychiatric problems at ages 6, 11, 16 and 19 years[27]. A study from the McMaster cohort also 
shows a lack of normative age-related decline in internalizing problems from adolescence to 
adulthood in individuals born ELBW[41]. .Furthermore in the EPICure study the effects of EP on 
psychiatric symptoms on the SDQ stayed similar from childhood to young adulthood[27], and 
previous studies show similar effects of VP/VLBW on ADHD and ASD across childhood, and 
adolescence and young adulthood ages [42–44]. Hence, while we included only studies assessing 
mental health phenotypes after 18 years of age, we do not know at which age these mental health 
disorders or symptoms had begun. This limits the conclusions that can be made of our findings 
being specific to adult age.  
 
Moreover, the literature is almost devoid of large-scale studies focusing on VP or VLBW adult 
mental health, especially those that report results stratified by age or birth year. Although, a handful 
of large Nordic register studies [12,13,16,35,36]  have analyzed mental health across the lifespan 
by gestational age and birth weight, the studies did not report the findings separately by age, birth 
year, or time of diagnosis. In parallel, the majority of the participants in the included studies were 
born in the late 1970s and 1980s, and only one study included participants born in the 1990s [27]. 
In light of the continuous improvements in neonatal medicine [45,46],  the adult mental health 
findings in our review, may not be generalizable to more modern born preterm adults, although 
more modern childhood and adolescent studies also show high frequencies of neurodevelopmental 
disabilities [47], psychiatric symptoms [48] , ASD [49]  and ADHD [50,51]. Therefore, neonatal 
medicine improvements may not necessarily translate to improvements in lifespan mental health 
of those surviving after VP/VLBW births as the risks related to these births remain. Meta-analytic 
evidence shows that ELBW birth predicts similarly increased parent and teacher-rated 
internalizing and externalizing problems, conduct disorders and ADHD problems in childhood in 
cohorts born before 1990s and in cohorts born since 1990 [9]. In addition, with a special focus on 
VP or VLBW born adult mental health, the findings of this review are not generalizable to broader 
preterm or low birth weight populations. However, Nordic register studies suggest dose-response 
effects of gestation length on psychotropic medication use and mental health disorders 
[12,13,33,34], with the highest risks observed among individual born EP, but with increased risks 
of the psychiatric phenotypes observed across the degrees of prematurity[12]. Finally, in a letter 
to the editor, the EPICure study[52] (excluded for publication type), found EP did not predict 
offspring depression or anxiety disorders or ASR total  or externalizing problems or its subscale 
scores at age 19 years. EP was associated with increased internalizing problems and its subscale 
scores, but only associations with anxiety problems remained significant after corrections for 
multiple testing. Small sample size and high attrition were factors limiting the generalizability of 
these findings[52]. The contradictory findings further suggests the need for larger scale studies in 




Our study has several important implications. While the data on mental health outcomes appearing 
in adulthood of VP/VLBW individuals remain limited and the pattern of findings between the 
different studies is mixed, the studies included in this systematic review encourage harmonizing 
and pooling data for aggregate-data and IPD meta-analyses using standardized measures and 
definitions. This will have several advantages over the individual studies that can help in 
overcoming the previous study limitations. These include increased statistical power to study rarer 
outcomes and to increase generalizability of the findings, and to study gestational age specific 
associations as well as identify factors fostering resiliency. This systematic review also points to 
the importance to follow-up the existing preterm cohorts as they age, to study if any mental health 
adversities extend to middle- or older-adulthood and to disorders that peak later in life e.g. 
Schizophrenia.  
 
While the current evidence is still limited, any longer-term mental health adversity following 
VP/VLBW birth will multiply the economic costs, especially given the high economic costs of 
mental health disorders for both the individual and the respective family. Besides mental health 
problems, VP/VLBW itself is the root of various direct (e.g. additional hospitalization) and indirect 
costs (e.g. labor market adjustments of the parents, more parenting time), which families and the 
respective preterm born individual have to bear. For example, using data from England and Wales 
in 2006 it has been estimated that the total cost of preterm birth to public sector was £2.946 billion 
(US $4.567 billion) and the incremental cost per VP child in comparison to term child surviving 
to 18 years was £61781 (US $95760) [11] . However, the costs depend on the actual development 
on the health care system and supply and hence are likely to differ from country to country. The 
same is true for the costs of mental health. The OECD estimates the costs of mental health 
problems at around 600 billion euro. This implies costs of ranging from two to more than five 




To our knowledge, this is the first systematic review focused on mental health outcomes appearing 
adults born VP or VLBW. The review provides a systematic, critical assessment of the quality of 
the evidence performed independently by two researchers, highlighting the key areas for 
improvement in future studies.  Our systematic review found consistent, moderate to high quality 
evidence that VP or VLBW born adults are at an increased risk for any psychotropic medication 
use, while in regards to their higher risk for mental health disorders appearing in adulthood and 
their symptoms the moderate to high quality evidence is mixed. The limitations in the current 
evidence signal a need for more high quality, large scale VP studies accounting for important 
covariates, through aggregate-data and/or IPD meta-analysis and register based studies.  
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Practice Points 
Adult mental health outcomes of individuals born VP/VLBW: 
• Lacks systematic reviews and assessment of the quality of evidence of the studies 
• Studies with moderate to high quality evidence 
• Use of psychotropic medication is higher, but evidence in regards to increased risk of 
mental disorders appearing in adulthood and symptoms remains uncertain. 
 
Research Directions 
Adult mental health outcomes of individuals born VP/VLBW: 
• Pooling and harmonizing data of exiting cohorts for aggregate-data and individual 
participant data meta-analyses and new large-scale studies to allow sufficient power 
for gestational age specific, year of birth- and age- stratified analyses and to allow 
studying outcomes with lower prevalence rates. 
• Extending follow-up of the preterm cohorts into middle- and older adulthood  
• Identification of sex-specificity and factors that foster resiliency
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